Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Expanded FDA Nod for Bone Solutions' Mg OSTEOINJECT - Orthopedic Design & Technology

What are you searching for?

Sign in
OEM News

Expanded FDA Nod for Bone Solutions’ Mg OSTEOINJECT

Expands the orthobiologic's indication to use as an adjunct to hardware

Author Image

By: Sam Brusco

Associate Editor

Orthobiologics firm Bone Solutions Inc. (BSI) has earned U.S. Food and Drug Administration (FDA) 510(k) clearance expanding indications for its Mg OSTEOINJECT drillable, adhesive, injectable bone void filler that incorporates magnesium for bone health and development.
 
The clearance expands the material’s indication to use as an adjunct to hardware fixation by supporting bone fragments during the surgical procedure.
 
Mg OSTEOINJECT is also a minimally invasive treatment for insufficiency and micro fractures via percutaneous skeletal fixation. Its adhesive properties and unique resorption profile provide stability, boosting cell proliferation and mineralization that results in enhance regeneration of bone in many orthopedic applications.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Add Orthopedic Design & Technology as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters

Topics